Metformin Experience on Minimal Hepatic Encephalopathy

Phase 4 Unknown 30 enrolled Andalusian Public Foundation for Health Research in Seville

RandomizedParallel-groupDouble-blindTreatment

Summary

Primary aim: -To assess the effect of metformin use on the treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. Secondary aim: -To evaluate if metformin is a safety drug in patients showing liver cirrhosis.

Timeline

Start: 2015-03
Primary completion: 2016-06
Completion: 2016-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Metformin	Small molecule	1000 mg	—

Metformin Experience on Minimal Hepatic Encephalopathy

Summary

Timeline

Drugs

Indications